Asthma

The FDA has approved dupilumab (Dupixent, Regeneron and Sanofi) in patients with moderate-to-severe asthma aged 12 years and older.

The FDA has approved dupilumab (Dupixent®, Regeneron and Sanofi) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.

Teva Pharmaceutical Industries Ltd has released Qvar Redihaler (beclomethasone dipropionate HFA).

One lot of Montelukast Sodium Tablets is being voluntarily recalled by Camber Pharmaceuticals, due to a safety risk for consumers.

More than 4 in 10 women with asthma may develop chronic obstructive pulmonary disorder, but many risk factors are modifiable.

Pharmacist-led interventions can increase medication adherence, and reduce its economic burden on healthcare.

Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.

A new research study, published in JAMA Cardiology, aimed to further confirm a previous correlation between asthma and atrial fibrillation (AF) and to determine if the degree of asthma control affected the risk of developing AF.

A lack of education leaves 31% of asthma/COPD patients with poor inhaler procedures.

Experts are beginning to see that some phenotypes respond better to certain treatment approaches for asthma.

In a recent study, researchers set out to identify the reasons why prescribers and pharmacists continue to prescribe NS β‐blockers despite the guidelines recommending against it.

Should emergency room clinicians use a breath-actuated nebulizer (BAN) or is a metered-dose inhaler (MDI) a better choice?

For health care providers, staying up to date on drug development trends is crucial to understanding the implications of these therapies and how they can best help their patients.

An emerging area of investigation in asthma and chronic obstructive pulmonary disease is use of statins.

A new study evaluated which interventions were effective at the point of discharge from the hospital to prevent readmission.

Antibiotics may worsen the care of some adult patients hospitalized with asthma exacerbations.

Prescription medication use for attention-deficit/hyperactivity disorder (ADHD), asthma, and contraception have all increased in children and teens.

A recent study looked at the benefits of digital health by tracking the use of SABAs to correlate hotspots of pollutants in the community. Using this data can lead to multiple policy changes for public health.

CVS Health's Chief Medical Officer Troyen A. Brennan, MD, outlined how the combination of data-driven insights, and the convenience of community-based retail health care can provide a highly personalized health care experience that supports the primary care medical home, and can improve patient outcomes and lower costs.

The utility of determining a patient's asthma phenotype is a current research priority, since various phenotypes seem to respond differently to interventions and medication.

Obstetricians and general practitioners most often field questions from women who have asthma, as this condition is more common than most other chronic conditions in young people.

Allergic diseases such as asthma were associated with a 1.66-fold increased hazard of psychiatric disorders in Taiwan.

Fewer than 1 in 10 pharmacists talked to most patients about asthma action plans routinely.

Clinicians who work with adolescents who have asthma report numerous adherence barriers.

Weather can exacerbate asthma, and one specific trigger is thunderstorm activity.

Children may have to skip school, be admitted to the hospital, and occasionally, children die from asthma attacks. That's a clear call for better intervention on the part of healthcare providers.

Childhood factors predisposed children to lung function decline and chronic obstructive pulmonary disease (COPD) as adults, according to 2 recent studies.

Smart Inhalers have been around for awhile, but have been consigned to use primarily in clinical trials. One company is bringing them to the OTC market.

Several new devices for the administration of inhaled medications have been introduced.